Abstract:Objective: The traditional Chinese medicine Anluohuaxianwan (ALHXW) has been used to treat liver fibrosis induced by chronic hepatitis B virus (HBV) infection. However, the anti-fibrosis mechanisms of ALHXW remain to be investigated. This study used a rat model of carbon tetrachloride (CCl(4))-induced liver fibrosis to explore the potential antifibrogenic mechanisms of ALHXW. Methods: Twenty-seven male Wistar rats were randomly assigned to control group, model group, and treatment group (n = 9 per group). Rats in the model and treatment group were injected intraperitoneally with 40% CCl(4)(2 ml/kg), and rats in the control group were administered saline twice a week for 6 weeks. Starting at week 4 following model construction, rats in the treatment group received daily gavages with ALHXW solution (concentration 0.15 g/ml) daily, while rats in the control and model groups were given saline for a total of 6 weeks. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured from blood samples collected at the end of weeks 3, 6 and 9. Histopathological examination of liver tissue was performed to evaluate liver fibrosis at week 9. At the same time, the mRNA expression of TGF-β1 and Smads in liver tissues was quantified by real-time reverse transcription polymerase chain reaction (RT-PCR), and TGF-β1 protein level in the liver was measured by Western blot. Inter-group comparison was performed using analysis of variance (ANOVA) when the continuous data were normally distributed and satisfied the homogeneity of variance; otherwise, nonparametric tests were used. Categorical data were compared between groups using nonparametric tests. Results: ALHXW markedly alleviated liver injury in the treatment group after 3 weeks of therapy as indicated by a significantly reduced level of ALT compared with the model group [(162.98 ± 73.14)U/L vs (322.52 ± 131.76)U/L, P = 0.047], and a 39.8% reduction in AST level compared with the model group[ (537.56 ± 306.06)U/L vs (892.98 ± 358.19)U/L, P = 0.053]. Moreover, at the end of the 6-week therapy, histopathological diagnosis showed that liver fibrosis was significantly reduced in the ALHXW-treated group compared with that in the model group (P = 0.002). The relative expression of TGF-β1 mRNA and protein in the liver were significantly lower in ALHXW-treated rats than that in model rats (1.34 ± 0.31 vs 1.78 ± 0.45, P = 0.025; 0.39 ± 0.02 vs 0.57 ± 0.04, P = 0.003). Conclusion: ALHXW treatment can reverse CCl(4)-induced liver fibrosis in rats. Its mechanisms of anti-fibrosis may occur through the inhibition of TGF-β1 synthesis and TGF-β1/Smads signaling pathway, which in turn suppress the activation of hepatic stellate cells and thereby reverses fibrosis.

Influences of Vitamin E on the Expression of Tissue Inhibitor of Metalloproteinase-2, Type III Collagen and Fibronectin in CCL_4-induced Rats Liver Fibrosis.

Effects of Vitamin E on the Proliferation and Collagen Synthesis of Rat Hepatic Stellate Cells Treated with Il-2 or Tnf-Alpha

[Effect of Silencing Connective Tissue Growth Factor on Rat Liver Fibrosis and the Accumulation of Extracellular Matrix].

Collagen-binding Vascular Endothelial Growth Factor Attenuates CCl4-induced Liver Fibrosis in Mice

[Effect of Anluohuaxianwan on the expression of matrix metalloproteinases and their inhibitors in rat liver with fibrosis]

Raav2-Tgf-β(3) Decreases Collagen Synthesis and Deposition in the Liver of Experimental Hepatic Fibrosis Rat.

Effects Of 18 Alpha-Glycyrrhizin On Tgf-Beta 1/Smad Signaling Pathway In Rats With Carbon Tetrachloride-Induced Liver Fibrosis

Efficacy of Activated Vitamin D3 Combined with Interferon-α in the Treatment of CCL4-induced Hepatic Fibrosis in Mice

Effects of 18Α-Glycyrrhizin on TGF-β1/Smad Signaling Pathway in Rats with Carbon Tetrachloride-Induced Liver Fibrosis.

Protein extracts of Crassostrea gigas alleviate CCl₄-induced hepatic fibrosis in rats by reducing the expression of CTGF, TGF-β1 and NF-κB in liver tissues.

Suppression of expression extracellular matrix in hepatic fibrosis rat with tetrandrine and glycyrrhizinic acid

Effects of curcumin on expression of collagen Ⅰ in fibrotic liver induced by carbon tetrachoride in rats

Effects of estrogen on the activation of hepatic stellate cells and collagen synthesis in liver fibrotic rats

Effect of 1 8αGlycyrrhizin on Regulating Collagen I expression in Fibrotic rat liver

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

[Effects of Anluohuaxianwan on Transforming Growth Factor-Β1 and Related Signaling Pathways in Rats with Carbon Tetrachloride-Induced Liver Fibrosis].

Toll-Like Receptor 3 Gene Deficiency Aggravates Carbon Tetrachloride-Induced Liver Fibrosis in Mice

Effects of imatinib mesylate on rat hepatic fibrogenesis and the expression of transforming growth factor-β1

Effect of the regulation of retinoid X receptor-α gene expression on rat hepatic fibrosis.

Expression of Αvβ3 Integrin and Platelet-Endothelial Cell Adhesion Molecule-1 in Progressive Liver Fibrosis: Experiment with Rats

Experimental study of tissue transglutaminase inhibitor on the progression of liver fibrosis